top of page
Frequently Asked Questions
- 01Our model is flexible and tailored to sponsor needs. You can access all CRDC hub locations, or work with selected sites. Regular PI oversight and central co-ordination ensure consistent delivery and rapid issue resolution. Central oversight, shared SOPs, regular performance review and experienced leadership ensure high-quality, consistent delivery across all CRDC locations.
- 02Sponsors contract once with University Hospital Southampton NHS Foundation Trust (UHS), which holds full legal and governance responsibility. This provides a single PI oversight model and one central project management team, significantly simplifying study set-up and delivery. Sponsors work with a single, dedicated CRDC project management team, providing a clear route for communication, escalation and reporting.
- 03Yes. The CRDC delivers both primary and secondary care studies and can support studies spanning both settings.
- 04Through our network of NHS organisations, we provide access to large, diverse and research-active patient populations across Wessex (Hampshire and Dorset).
- 05The CRDC model is designed to accelerate study set -up through centralised governance, contracting and coordinated site activation.
- 06Multiple sites can be activated in parallel under the single contract and oversight model, enabling rapid scale-up.
- 07The CRDC supports a broad range of therapeutic areas, drawing on experienced investigators and established NHS and NIHR infrastructure.
- 08The CRDC has delivered a wide range of commercial studies at scale and pace, supporting global sponsors to meet recruitment and delivery targets.
- 09IMP management is coordinated through experienced centralised NHS pharmacy teams, ensuring consistent handling, distribution and compliance across all participating sites.
bottom of page
